Story excerpt provided by Crain’s Cleveland Business.
Written by Beth Thomas Hertz.
An idea that started in a lab at the University of Akron to help streamline the development of cancer drugs has led to a $150,000 grant from the Ohio Third Frontier Commission for the company that has been formed to commercialize the technology, OncoSolutions LLC.
The idea came from the lab of Hossein Tavana, an associate professor of biomedical engineering. It involves the creation of three-dimensional polymer models of cancer tumors that can be used to test potential drugs. The pharmaceutical industry currently screens early investigational drugs with two-dimensional, or flat, layers of cancer cells. The drugs that pass this screen may move forward into animal studies, but up to 80% of them will fail that next phase.
Click here to read the complete article.
Originally published April 30, 2017.